{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:51:16Z","timestamp":1791399076782,"version":"4.3.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05937-y","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:15:42Z","timestamp":1789784142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TRIM28 facilitates diffuse large B-cell lymphoma progression by inducing glycolytic reprogramming through the E2F1\/PKM2 axis"],"prefix":"10.1007","author":[{"given":"Liuyan","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"5937_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.3202","volume":"42","author":"A Barraclough","year":"2024","unstructured":"Barraclough A, Hawkes E, Sehn LH, Smith SM (2024) Diffuse large B-cell lymphoma. Hematol Oncol 42:e3202","journal-title":"Hematol Oncol"},{"key":"5937_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1659011","volume":"16","author":"C Chen","year":"2025","unstructured":"Chen C, Guo W, Wang H, Cao L, Bai O (2025) Metabolic-immune axis in the tumor microenvironment: a new strategy for prognostic assessment and precision therapy in DLBCL and FL. Front Immunol 16:1659011","journal-title":"Front Immunol"},{"key":"5937_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40364-024-00605-w","volume":"12","author":"L Dai","year":"2024","unstructured":"Dai L, Fan G, Xie T et al (2024) Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma. Biomark Res 12:58","journal-title":"Biomark Res"},{"key":"5937_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18040701","author":"YE Ding","year":"2026","unstructured":"Ding YE, Zhong YR, Zhang LS, Xu L, Li J, Wen Y (2026) Lipid metabolism reprogramming in diffuse large B-cell lymphoma (DLBCL): mechanisms and treatment strategies. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers18040701","journal-title":"Cancers (Basel)"},{"key":"5937_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18010075","author":"Y Du","year":"2025","unstructured":"Du Y, Liu Z, Liu C et al (2025) Glycolysis-driven immune subtypes in the tumor microenvironment determine clinical outcomes in diffuse large B-cell lymphoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers18010075","journal-title":"Cancers (Basel)"},{"key":"5937_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1675677","volume":"16","author":"H Duan","year":"2025","unstructured":"Duan H, Xu B, Luo P, Chen T, Zou J (2025) Microbial metabolites and their influence on the tumor microenvironment. Front Immunol 16:1675677","journal-title":"Front Immunol"},{"key":"5937_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ygyno.2025.09.008","volume":"202","author":"F Geng","year":"2025","unstructured":"Geng F, Wang Y, Cui G, Fan M (2025) TRIB3 promotes endometrial cancer progression through interacting with E2F1 and enhancing PKM2-mediated tumor glycolysis. Gynecol Oncol 202:41\u201352","journal-title":"Gynecol Oncol"},{"key":"5937_CR8","doi-asserted-by":"crossref","unstructured":"Haraldsdottir H, Brondum RF, Enemark MH et al (2025) Proteomic Study of Diffuse Large B-Cell Lymphoma Identifying Proteins Associated with R-CHOP Response. Biomedicines 13","DOI":"10.3390\/biomedicines13112709"},{"key":"5937_CR9","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1016\/j.devcel.2025.07.023","volume":"60","author":"D Hong","year":"2025","unstructured":"Hong D, Lyu Y, Nayak R et al (2025) Loss of NOTCH2 creates a TRIM28-dependent vulnerability in small cell lung cancer. Dev Cell 60:3462\u201379 e13","journal-title":"Dev Cell"},{"issue":"1","key":"5937_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13046-022-02412-3","volume":"41","author":"Z Jing","year":"2022","unstructured":"Jing Z, Liu Q, He X et al (2022) NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer. J Exp Clin Cancer Res 41:198","journal-title":"J Exp Clin Cancer Res"},{"key":"5937_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217612","volume":"617","author":"C Jiang","year":"2025","unstructured":"Jiang C, Qian Y, Bai X et al (2025) SLC7A5\/E2F1\/PTBP1\/PKM2 axis mediates progression and therapy effect of triple-negative breast cancer through the crosstalk of amino acid metabolism and glycolysis pathway. Cancer Lett 617:217612","journal-title":"Cancer Lett"},{"key":"5937_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1158\/1541-7786.MCR-25-0676","volume":"24","author":"M Kim","year":"2026","unstructured":"Kim M, Cong H, Goettl R, Liu J, Fong KW (2026) Bone Metastatic Progression of Prostate Cancer Is Regulated by TRIM28-LDHA-Mediated Metabolism. Mol Cancer Res 24:93\u2013105","journal-title":"Mol Cancer Res"},{"key":"5937_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI185119","author":"M Kim","year":"2025","unstructured":"Kim M, Liu J, Zhang Y et al (2025) RSK1-driven TRIM28\/E2F1 feedback loop promotes castration-resistant prostate cancer progression. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI185119","journal-title":"J Clin Invest"},{"issue":"1","key":"5937_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41698-025-00964-z","volume":"9","author":"MH Li","year":"2025","unstructured":"Li MH, Wang T, Guan XH et al (2025) TRIM65 regulates glucose metabolic reprogramming to promote glioma cell proliferation via ubiquitination and degradation of AMPK. NPJ Precis Oncol 9:163","journal-title":"NPJ Precis Oncol"},{"key":"5937_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/2643-3230.BCD-20-0183","volume":"3","author":"M Li","year":"2022","unstructured":"Li M, Teater MR, Hong JY et al (2022) Translational activation of ATF4 through mitochondrial anaplerotic metabolic pathways is required for DLBCL growth and survival. Blood Cancer Discov 3:50\u201365","journal-title":"Blood Cancer Discov"},{"key":"5937_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1704254","volume":"17","author":"Y Li","year":"2026","unstructured":"Li Y, Zhang Y, Zhu C et al (2026) Novel immunotherapeutic strategies for diffuse large B-cell lymphoma: a comprehensive review. Front Immunol 17:1704254","journal-title":"Front Immunol"},{"key":"5937_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2026.2648193","volume":"27","author":"Y Liang","year":"2026","unstructured":"Liang Y, Wang C, Ren T et al (2026) The MYBL2-GTSE1 axis promotes laryngeal squamous cell carcinoma progression by regulating PI3K\/AKT-dependent glycolytic reprogramming. Cancer Biol Ther 27:2648193","journal-title":"Cancer Biol Ther"},{"key":"5937_CR18","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.trecan.2025.06.013","volume":"11","author":"JK Lue","year":"2025","unstructured":"Lue JK, Healton SE, Salles GA (2025) Leveraging immunologically based therapies to treat diffuse large B-cell lymphoma. Trends Cancer 11:1118\u20131129","journal-title":"Trends Cancer"},{"key":"5937_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-026-15654-7","author":"X Song","year":"2026","unstructured":"Song X, Fu H, Zhong X, Yu N, Zhang W (2026) P300 enhances glycolysis and dox resistance in DLBCL by upregulating HK2 expression through histone lactylation. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-026-15654-7","journal-title":"BMC Cancer"},{"issue":"9","key":"5937_CR20","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41419-022-05208-7","volume":"13","author":"T Tian","year":"2022","unstructured":"Tian T, Li J, Shi D et al (2022) SMYD3 promotes aerobic glycolysis in diffuse large B-cell lymphoma via H3K4me3-mediated PKM2 transcription. Cell Death Dis 13:763","journal-title":"Cell Death Dis"},{"key":"5937_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/hon.70119","volume":"43","author":"Y Wang","year":"2025","unstructured":"Wang Y, Li B, Zhao Y et al (2025) Deubiquitinase TRIM44 promotes autophagy-mediated chemoresistance in diffuse large B cell lymphoma. Hematol Oncol 43:e70119","journal-title":"Hematol Oncol"},{"key":"5937_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3440","volume":"24","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yang F, Peng Q, Mei K, He H, Yang Q (2022) Long non-coding RNA SNHG1 activates glycolysis to promote hepatocellular cancer progression through the miR-326\/PKM2 axis. J Gene Med 24:e3440","journal-title":"J Gene Med"},{"key":"5937_CR23","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.62347\/LAQY2536","volume":"15","author":"Y Wu","year":"2025","unstructured":"Wu Y, Li ZJ, Li M, Wang M, Feng QY, Xi YM (2025) Enhanced glycolysis induced by activation of AKT\/NF-kappaB signaling pathway contributes to doxorubicin resistance in DLBCL. Am J Cancer Res 15:3904\u20133918","journal-title":"Am J Cancer Res"},{"key":"5937_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.25259\/Cytojournal_90_2025","volume":"23","author":"L Xin","year":"2026","unstructured":"Xin L, Han S, Wang Z et al (2026) Tripartite motif-containing protein 28 promotes drug resistance to bortezomib in gastric cancer through proteasome activity regulation. Cytojournal 23:5","journal-title":"Cytojournal"},{"key":"5937_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1186\/s12967-025-06905-5","volume":"23","author":"L Yan","year":"2025","unstructured":"Yan L, Sun Y, Shi SS et al (2025) Triclabendazole inhibits PKM2 nuclear localization and glycolysis by enhancing HDAC6-mediated deacetylation in lung cancer. J Transl Med 23:1001","journal-title":"J Transl Med"},{"key":"5937_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2123231119","volume":"119","author":"H Yu","year":"2022","unstructured":"Yu H, Wang M, Zhang T et al (2022) Dual roles of beta-arrestin 1 in mediating cell metabolism and proliferation in gastric cancer. Proc Natl Acad Sci U S A 119:e2123231119","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05937-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05937-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05937-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:02:20Z","timestamp":1791396140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05937-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":26,"alternative-id":["5937"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05937-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The author noticed that there are 2 affiliations for Jiaqi Yu. Jiaqi Yu only has one affiliation, which is affiliation 3 (The First Clinical College, Gannan Medical University, Rongjiang New District University Park, Ganzhou, China).","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments and protocols were approved by The First Affiliated Hospital of Gannan Medical University (No. 2026\u2013065).","order":1,"name":"Ethics","label":"Ethical statements","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}